Roche Wins Dual FDA Approvals for Breast Cancer and Chronic Kidney Disease Therapies
Tickers: $RHHBY
Topics: breast cancer chronic kidney disease FDA approval pharmaceuticals
Read the full article at Benzinga
Part of the story FDA Approves Roche's Oral Breast Cancer Therapy Wilserdly (2 articles)